# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Idiopathic pulmonary fibrosis

Familial pulmonary fibrosis
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 41-50 of 364 results.
Human Autologous Lung Stem Cell Transplant for Idiopathic Pulmonary Fibrosis
Status: Recruiting
Last Changed: Oct 23, 2020
First Received: Feb 10, 2020
Disease(s): Idiopathic Pulmonary Fibrosis
Intervention(s): Lung Spheroid Stem Cells 100 million, Lung Spheroid Stem Cells 200 million
Locations: University of North Carolina as Chapel Hill, Chapel Hill, North Carolina, United States
A Study to Evaluate Long Term Safety and Efficacy of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis
Status: Not yet recruiting
Last Changed: Oct 20, 2020
First Received: Oct 20, 2020
Disease(s): Idiopathic Pulmonary Fibrosis
Intervention(s): PRM-151
Locations: Central Florida Pulmonary Group, PA, Orlando, Florida, United States
Lung Cancer and Idiopathic Pulmonary Fibrosis : Pathological and Molecular Characterization
Status: Unknown status
Last Changed: Oct 11, 2018
First Received: Apr 03, 2018
Disease(s): Lung Cancer and Idiopathic Pulmonary Fibrosis
Locations: Hopital BICHAT-CLAUDE BERNARD, Paris, France
Real-Life Use of Anti-fibrotic Drugs in Patients With Idiopathic Pulmonary Fibrosis in Sweden
Status: Recruiting
Last Changed: Jul 15, 2019
First Received: Jul 15, 2019
Disease(s): Idiopathic Pulmonary Fibrosis
Intervention(s): Anti-fibrostic drugs
Locations: Karolinska University Hospital, Stockholm, Sweden
A Study to Evaluate the Efficacy and Safety of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis
Status: Not yet recruiting
Last Changed: Oct 08, 2020
First Received: Sep 17, 2020
Disease(s): Idiopathic Pulmonary Fibrosis
Intervention(s): PRM-151, Placebo
Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis
Status: Recruiting
Last Changed: Feb 05, 2019
First Received: Oct 30, 2017
Disease(s): Idiopathic Pulmonary Fibrosis
Intervention(s): Pulmonary rehabilitation
Locations: Corfu General Hospital, Corfu, Greece
Evaluation of Efficacy and Safety of PLN-74809 in Patients With Idiopathic Pulmonary Fibrosis
Status: Recruiting
Last Changed: Sep 10, 2020
First Received: May 21, 2020
Disease(s): Idiopathic Pulmonary Fibrosis
Intervention(s): PLN-74809, Placebo
Locations: Central Florida Pulmonary Group, Orlando, Florida, United States
Emory Clinic, Atlanta, Georgia, United States
Piedmont Healthcare Pulmonary and Critical Care Research, Austell, Georgia, United States
St. Luke's Hospital, Chesterfield, Missouri, United States
Pulmonary and Allergy Associates, Summit, New Jersey, United States
... and 5 other locations.
Muscle Stimulation in Advanced Idiopathic Pulmonary Fibrosis
Status: Completed
Last Changed: Oct 08, 2020
First Received: Apr 17, 2018
Disease(s): Idiopathic Pulmonary Fibrosis
Intervention(s): Active NMES, Sham NMES, Home exercise programme, Breathlessness advice
Locations: Royal Brompton and Harefield NHS Foundation Trust, Harefield, Middlesex, United Kingdom
Integrating Palliative Care for Patients With Idiopathic Pulmonary Fibrosis and Their Caregivers
Status: Completed
Last Changed: Aug 07, 2020
First Received: Oct 10, 2016
Disease(s): Idiopathic Pulmonary Fibrosis
Intervention(s): SUPPORT, Currently Available Printed Material
Locations: Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease, Pittsburgh, Pennsylvania, United States
GKT137831 in IPF Patients With Idiopathic Pulmonary Fibrosis
Status: Recruiting
Last Changed: Sep 16, 2020
First Received: Mar 07, 2019
Disease(s): Idiopathic Pulmonary Fibrosis
Intervention(s): Placebo Oral Tablet, GKT137831
Locations: University of Alabama at Birmingham, Birmingham, Alabama, United States